PROVIDER PROFILE · NPI 1114191731

James Nash

Nurse PractitionerNashville, TNI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

235

Beneficiaries

—

Total drug cost

$794K

Distinct drugs

Brand share

100.0%

Top prescribed drugs

Bictegrav/Emtricit/Tenofov Ala78 claims

Abacavir/Dolutegravir/Lamivudi59 claims

Emtricitabine/Tenofov Alafenam27 claims

Elviteg/Cob/Emtri/Tenof Alafen26 claims

Dolutegravir Sodium25 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where James Nash's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
VANDERBILT UNIVERSITY MEDICAL CENTER	44	183
RAFFANTI, STEPHEN	14	38

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
VANDERBILT UNIVERSITY MEDICAL CENTER	97	419
Catherine Mcgowan Internal Medicine · Nashville, TN	27	45
RAFFANTI, STEPHEN	25	53
Anna Person Infectious Disease · Nashville, TN	15	23

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history